ResourceDrug discovery > Lead Discovery
Multi-pass transmembrane proteins and technology platforms
7 Mar 2022The VLP (Virus like particles) technology based on the HEK293 expression system is specially set up by ACROBiosystems. It can directly aggregate membrane proteins with a complete conformation on the cell surface, turning these complex membrane proteins into soluble, high-concentration proteins for antibody immunization and screening. In this application note, find the full range, and key benefits of VLP technology.
Links
Tags
Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Membrane Proteins